Yuri Agrawal
Concepts (317)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vestibular Diseases | 28 | 2025 | 53 | 9.820 |
Why?
| | Vestibule, Labyrinth | 18 | 2025 | 91 | 6.030 |
Why?
| | Postural Balance | 17 | 2025 | 237 | 4.630 |
Why?
| | Aging | 27 | 2025 | 1917 | 4.410 |
Why?
| | Accidental Falls | 18 | 2025 | 213 | 4.150 |
Why?
| | Reflex, Vestibulo-Ocular | 14 | 2022 | 26 | 4.020 |
Why?
| | Vertigo | 14 | 2024 | 53 | 3.780 |
Why?
| | Vestibular Evoked Myogenic Potentials | 14 | 2025 | 17 | 3.640 |
Why?
| | Alzheimer Disease | 9 | 2023 | 594 | 3.310 |
Why?
| | Vestibular Function Tests | 21 | 2025 | 36 | 3.170 |
Why?
| | Spatial Navigation | 5 | 2024 | 16 | 2.830 |
Why?
| | Cognitive Dysfunction | 8 | 2024 | 408 | 2.730 |
Why?
| | Saccule and Utricle | 6 | 2024 | 13 | 2.140 |
Why?
| | Semicircular Canals | 9 | 2020 | 33 | 2.070 |
Why?
| | Hearing Loss | 11 | 2024 | 234 | 2.030 |
Why?
| | Dizziness | 11 | 2023 | 94 | 2.030 |
Why?
| | Cross-Sectional Studies | 38 | 2025 | 5645 | 1.820 |
Why?
| | Longitudinal Studies | 27 | 2025 | 2920 | 1.790 |
Why?
| | Head Movements | 8 | 2022 | 32 | 1.620 |
Why?
| | Virtual Reality | 3 | 2024 | 74 | 1.540 |
Why?
| | Aged | 65 | 2025 | 24666 | 1.510 |
Why?
| | Aged, 80 and over | 33 | 2025 | 7899 | 1.470 |
Why?
| | Physical Therapy Modalities | 3 | 2021 | 318 | 1.330 |
Why?
| | Otologic Surgical Procedures | 8 | 2016 | 21 | 1.310 |
Why?
| | Baltimore | 11 | 2024 | 68 | 1.270 |
Why?
| | Gait | 5 | 2022 | 315 | 1.260 |
Why?
| | Head Impulse Test | 8 | 2019 | 9 | 1.260 |
Why?
| | Cognition Disorders | 3 | 2019 | 513 | 1.160 |
Why?
| | Vision Disorders | 5 | 2022 | 167 | 1.090 |
Why?
| | Eye Movements | 5 | 2015 | 87 | 1.060 |
Why?
| | Humans | 113 | 2025 | 140898 | 1.050 |
Why?
| | Ear, Inner | 2 | 2025 | 52 | 0.980 |
Why?
| | Neuroma, Acoustic | 5 | 2014 | 55 | 0.970 |
Why?
| | Male | 73 | 2025 | 69893 | 0.950 |
Why?
| | Middle Aged | 52 | 2025 | 34487 | 0.940 |
Why?
| | Sensorimotor Cortex | 1 | 2025 | 5 | 0.940 |
Why?
| | Female | 74 | 2025 | 75540 | 0.920 |
Why?
| | Entorhinal Cortex | 1 | 2025 | 15 | 0.910 |
Why?
| | Independent Living | 3 | 2024 | 112 | 0.860 |
Why?
| | Frontal Lobe | 1 | 2025 | 161 | 0.840 |
Why?
| | Prevalence | 15 | 2022 | 2780 | 0.830 |
Why?
| | Meniere Disease | 3 | 2014 | 35 | 0.830 |
Why?
| | Telerehabilitation | 1 | 2024 | 39 | 0.830 |
Why?
| | Health Surveys | 8 | 2018 | 511 | 0.830 |
Why?
| | Neurotology | 3 | 2018 | 5 | 0.770 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 316 | 0.730 |
Why?
| | Nutrition Surveys | 7 | 2021 | 280 | 0.710 |
Why?
| | Walking Speed | 2 | 2022 | 50 | 0.700 |
Why?
| | Adult | 43 | 2024 | 39134 | 0.680 |
Why?
| | Orientation, Spatial | 1 | 2021 | 12 | 0.680 |
Why?
| | Healthy Aging | 1 | 2021 | 37 | 0.660 |
Why?
| | Saccades | 3 | 2017 | 45 | 0.650 |
Why?
| | Surveys and Questionnaires | 9 | 2023 | 5931 | 0.610 |
Why?
| | Proprioception | 1 | 2019 | 27 | 0.590 |
Why?
| | Space Perception | 2 | 2018 | 86 | 0.570 |
Why?
| | Bilateral Vestibulopathy | 1 | 2018 | 1 | 0.560 |
Why?
| | Bone Conduction | 3 | 2014 | 24 | 0.540 |
Why?
| | Otolithic Membrane | 2 | 2019 | 6 | 0.530 |
Why?
| | United States | 21 | 2024 | 15195 | 0.520 |
Why?
| | Accidents, Traffic | 1 | 2018 | 190 | 0.520 |
Why?
| | Developmental Disabilities | 1 | 2019 | 284 | 0.500 |
Why?
| | Frailty | 3 | 2025 | 176 | 0.500 |
Why?
| | Activities of Daily Living | 3 | 2016 | 425 | 0.500 |
Why?
| | Social Participation | 1 | 2016 | 28 | 0.490 |
Why?
| | Risk Factors | 14 | 2023 | 10430 | 0.480 |
Why?
| | Automobile Driving | 1 | 2018 | 152 | 0.470 |
Why?
| | Referral and Consultation | 1 | 2021 | 794 | 0.460 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 435 | 0.450 |
Why?
| | Hearing | 3 | 2023 | 123 | 0.440 |
Why?
| | Psychotropic Drugs | 1 | 2015 | 74 | 0.440 |
Why?
| | Self Report | 2 | 2021 | 858 | 0.440 |
Why?
| | Eye Movement Measurements | 1 | 2014 | 14 | 0.420 |
Why?
| | Hearing Loss, Noise-Induced | 2 | 2012 | 15 | 0.420 |
Why?
| | Reaction Time | 2 | 2015 | 430 | 0.420 |
Why?
| | Auditory Threshold | 3 | 2012 | 46 | 0.410 |
Why?
| | Walking | 5 | 2022 | 541 | 0.410 |
Why?
| | Prospective Studies | 9 | 2023 | 7749 | 0.410 |
Why?
| | Visual Perception | 1 | 2015 | 177 | 0.400 |
Why?
| | Turner Syndrome | 1 | 2014 | 65 | 0.390 |
Why?
| | Petrous Bone | 1 | 2012 | 8 | 0.390 |
Why?
| | Bone Cysts | 1 | 2012 | 11 | 0.390 |
Why?
| | Sleep Wake Disorders | 1 | 2017 | 304 | 0.390 |
Why?
| | Hippocampus | 1 | 2018 | 939 | 0.380 |
Why?
| | Health Status Disparities | 1 | 2016 | 297 | 0.380 |
Why?
| | Olfaction Disorders | 2 | 2023 | 70 | 0.380 |
Why?
| | Bone Density | 1 | 2016 | 495 | 0.370 |
Why?
| | Ear Canal | 1 | 2012 | 16 | 0.360 |
Why?
| | Mouth Diseases | 2 | 2009 | 46 | 0.360 |
Why?
| | Point-of-Care Systems | 1 | 2014 | 187 | 0.360 |
Why?
| | Hypersensitivity | 1 | 2014 | 260 | 0.340 |
Why?
| | Tinnitus | 3 | 2022 | 60 | 0.340 |
Why?
| | Ear Neoplasms | 1 | 2010 | 10 | 0.330 |
Why?
| | Cohort Studies | 9 | 2024 | 5789 | 0.330 |
Why?
| | Body Weight | 1 | 2015 | 992 | 0.330 |
Why?
| | Electronic Health Records | 1 | 2018 | 1125 | 0.330 |
Why?
| | Mobility Limitation | 3 | 2022 | 63 | 0.330 |
Why?
| | Noise, Occupational | 1 | 2010 | 4 | 0.330 |
Why?
| | Audiometry | 4 | 2012 | 31 | 0.320 |
Why?
| | Odds Ratio | 5 | 2016 | 1054 | 0.320 |
Why?
| | Frail Elderly | 3 | 2025 | 132 | 0.310 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 562 | 0.310 |
Why?
| | Cardiovascular Diseases | 4 | 2015 | 2082 | 0.310 |
Why?
| | Socioeconomic Factors | 4 | 2017 | 1310 | 0.300 |
Why?
| | Diabetes Complications | 1 | 2010 | 222 | 0.300 |
Why?
| | Logistic Models | 5 | 2019 | 2088 | 0.290 |
Why?
| | Human papillomavirus 16 | 1 | 2008 | 31 | 0.290 |
Why?
| | Cognition | 4 | 2023 | 1220 | 0.290 |
Why?
| | Regression Analysis | 3 | 2017 | 1015 | 0.280 |
Why?
| | Smell | 3 | 2023 | 131 | 0.280 |
Why?
| | Magnetic Resonance Imaging | 5 | 2025 | 3724 | 0.280 |
Why?
| | Papillomavirus Infections | 2 | 2009 | 363 | 0.260 |
Why?
| | Severity of Illness Index | 2 | 2014 | 2898 | 0.260 |
Why?
| | Cytotoxins | 1 | 2006 | 16 | 0.240 |
Why?
| | Mental Disorders | 1 | 2015 | 1123 | 0.240 |
Why?
| | Azathioprine | 1 | 2006 | 51 | 0.240 |
Why?
| | Multivariate Analysis | 5 | 2024 | 1496 | 0.240 |
Why?
| | Laryngeal Diseases | 1 | 2006 | 32 | 0.240 |
Why?
| | Neuropsychological Tests | 3 | 2023 | 1089 | 0.230 |
Why?
| | Rotation | 3 | 2015 | 121 | 0.230 |
Why?
| | Risk | 3 | 2015 | 903 | 0.220 |
Why?
| | Population Surveillance | 1 | 2008 | 479 | 0.220 |
Why?
| | Postoperative Period | 4 | 2016 | 360 | 0.220 |
Why?
| | Temporal Bone | 2 | 2016 | 43 | 0.220 |
Why?
| | Head and Neck Neoplasms | 2 | 2009 | 553 | 0.210 |
Why?
| | Retrospective Studies | 11 | 2024 | 16315 | 0.210 |
Why?
| | International Classification of Diseases | 1 | 2025 | 138 | 0.210 |
Why?
| | Treatment Outcome | 9 | 2018 | 11125 | 0.210 |
Why?
| | Sarcoidosis | 1 | 2006 | 163 | 0.210 |
Why?
| | Visual Acuity | 4 | 2021 | 447 | 0.200 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 640 | 0.200 |
Why?
| | Geriatric Assessment | 3 | 2025 | 225 | 0.200 |
Why?
| | Young Adult | 11 | 2024 | 13646 | 0.190 |
Why?
| | Adolescent | 10 | 2024 | 22027 | 0.190 |
Why?
| | Mastoiditis | 1 | 2022 | 7 | 0.190 |
Why?
| | Bullying | 1 | 2023 | 44 | 0.190 |
Why?
| | Cerebellopontine Angle | 2 | 2012 | 8 | 0.190 |
Why?
| | Disability Evaluation | 2 | 2016 | 303 | 0.180 |
Why?
| | White Matter | 1 | 2024 | 147 | 0.180 |
Why?
| | Neurodegenerative Diseases | 1 | 2024 | 139 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.180 |
Why?
| | Hearing Loss, Sudden | 1 | 2021 | 7 | 0.180 |
Why?
| | Sensation Disorders | 1 | 2021 | 39 | 0.180 |
Why?
| | Incidence | 4 | 2021 | 2782 | 0.180 |
Why?
| | Reference Values | 2 | 2014 | 803 | 0.170 |
Why?
| | Exercise Therapy | 1 | 2025 | 450 | 0.170 |
Why?
| | Motion Perception | 1 | 2021 | 19 | 0.170 |
Why?
| | Risk Assessment | 6 | 2018 | 3484 | 0.170 |
Why?
| | Immunosuppressive Agents | 1 | 2006 | 854 | 0.170 |
Why?
| | Crime Victims | 1 | 2023 | 130 | 0.170 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2021 | 80 | 0.170 |
Why?
| | Ear Diseases | 2 | 2018 | 17 | 0.170 |
Why?
| | Migraine Disorders | 1 | 2022 | 106 | 0.160 |
Why?
| | Anesthesiology | 1 | 2023 | 170 | 0.160 |
Why?
| | Neurosurgical Procedures | 2 | 2012 | 197 | 0.160 |
Why?
| | Postoperative Complications | 4 | 2016 | 2813 | 0.160 |
Why?
| | Data Collection | 1 | 2023 | 651 | 0.160 |
Why?
| | Caloric Tests | 1 | 2019 | 3 | 0.150 |
Why?
| | Environmental Exposure | 2 | 2016 | 578 | 0.140 |
Why?
| | Age Factors | 3 | 2016 | 3278 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 250 | 0.140 |
Why?
| | Healthy Volunteers | 1 | 2019 | 214 | 0.140 |
Why?
| | Efficiency | 1 | 2018 | 101 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2019 | 352 | 0.130 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 876 | 0.130 |
Why?
| | Labyrinth Diseases | 1 | 2016 | 8 | 0.130 |
Why?
| | Otolaryngology | 1 | 2018 | 106 | 0.130 |
Why?
| | Eustachian Tube | 1 | 2016 | 8 | 0.130 |
Why?
| | Melanins | 1 | 2016 | 17 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 2022 | 2760 | 0.120 |
Why?
| | Audiometry, Pure-Tone | 2 | 2012 | 32 | 0.120 |
Why?
| | Immunotherapy | 1 | 2020 | 643 | 0.120 |
Why?
| | Pigmentation | 1 | 2016 | 54 | 0.120 |
Why?
| | Marital Status | 1 | 2016 | 46 | 0.120 |
Why?
| | Case-Control Studies | 3 | 2019 | 3578 | 0.120 |
Why?
| | Denervation | 1 | 2015 | 25 | 0.120 |
Why?
| | Vestibular Nerve | 1 | 2015 | 19 | 0.120 |
Why?
| | Nervous System Diseases | 1 | 2018 | 277 | 0.120 |
Why?
| | Interviews as Topic | 2 | 2016 | 841 | 0.120 |
Why?
| | Linear Models | 1 | 2018 | 854 | 0.120 |
Why?
| | Smoke | 1 | 2016 | 148 | 0.120 |
Why?
| | Confusion | 1 | 2015 | 31 | 0.110 |
Why?
| | Brain | 2 | 2024 | 2852 | 0.110 |
Why?
| | Comorbidity | 1 | 2019 | 1658 | 0.110 |
Why?
| | Hospital Rapid Response Team | 1 | 2014 | 21 | 0.110 |
Why?
| | Speech Perception | 2 | 2012 | 88 | 0.110 |
Why?
| | Environment | 1 | 2016 | 341 | 0.110 |
Why?
| | Physicians | 1 | 2023 | 928 | 0.110 |
Why?
| | Memory Disorders | 1 | 2015 | 182 | 0.100 |
Why?
| | Nystagmus, Pathologic | 1 | 2014 | 17 | 0.100 |
Why?
| | Airway Management | 1 | 2014 | 71 | 0.100 |
Why?
| | Ocular Motility Disorders | 1 | 2014 | 33 | 0.100 |
Why?
| | Sex Characteristics | 1 | 2019 | 785 | 0.100 |
Why?
| | Melanoma | 1 | 2020 | 792 | 0.100 |
Why?
| | Atrophy | 2 | 2024 | 196 | 0.100 |
Why?
| | Acoustic Stimulation | 1 | 2015 | 324 | 0.100 |
Why?
| | Locomotion | 1 | 2014 | 106 | 0.100 |
Why?
| | Sickness Impact Profile | 1 | 2013 | 58 | 0.100 |
Why?
| | Laryngoscopy | 1 | 2014 | 118 | 0.100 |
Why?
| | Refractive Errors | 1 | 2013 | 35 | 0.100 |
Why?
| | Benign Paroxysmal Positional Vertigo | 1 | 2013 | 6 | 0.100 |
Why?
| | Mucocele | 1 | 2012 | 13 | 0.100 |
Why?
| | Encephalocele | 1 | 2012 | 12 | 0.100 |
Why?
| | Quality Improvement | 2 | 2018 | 1234 | 0.100 |
Why?
| | Video Recording | 1 | 2014 | 197 | 0.100 |
Why?
| | Carcinoma, Adenoid Cystic | 1 | 2012 | 18 | 0.100 |
Why?
| | Antigens, Differentiation | 1 | 2012 | 83 | 0.100 |
Why?
| | Cranial Fossa, Middle | 1 | 2012 | 17 | 0.100 |
Why?
| | Salivary Gland Neoplasms | 1 | 2012 | 38 | 0.090 |
Why?
| | Recurrence | 1 | 2016 | 1104 | 0.090 |
Why?
| | Vocal Cord Paralysis | 1 | 2012 | 28 | 0.090 |
Why?
| | Smoking | 2 | 2010 | 1573 | 0.090 |
Why?
| | Age Distribution | 2 | 2013 | 397 | 0.090 |
Why?
| | Depressive Disorder | 1 | 2015 | 374 | 0.090 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 288 | 0.090 |
Why?
| | Sex Distribution | 2 | 2013 | 381 | 0.090 |
Why?
| | Anxiety Disorders | 1 | 2015 | 373 | 0.090 |
Why?
| | Sex Factors | 2 | 2015 | 2051 | 0.090 |
Why?
| | Motor Activity | 1 | 2016 | 718 | 0.090 |
Why?
| | Endolymphatic Hydrops | 1 | 2010 | 4 | 0.080 |
Why?
| | Respiratory Insufficiency | 1 | 2014 | 325 | 0.080 |
Why?
| | Functional Laterality | 1 | 2012 | 242 | 0.080 |
Why?
| | Educational Status | 1 | 2012 | 462 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3336 | 0.080 |
Why?
| | Medicare | 1 | 2016 | 806 | 0.080 |
Why?
| | Exercise | 1 | 2021 | 2108 | 0.080 |
Why?
| | Deglutition Disorders | 1 | 2011 | 151 | 0.080 |
Why?
| | Diabetic Neuropathies | 1 | 2010 | 94 | 0.080 |
Why?
| | Microsurgery | 1 | 2010 | 77 | 0.080 |
Why?
| | Mental Health | 1 | 2016 | 753 | 0.080 |
Why?
| | Sleep | 1 | 2017 | 879 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 433 | 0.080 |
Why?
| | Reoperation | 1 | 2012 | 590 | 0.070 |
Why?
| | Craniotomy | 1 | 2009 | 78 | 0.070 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2009 | 54 | 0.070 |
Why?
| | Qualitative Research | 1 | 2016 | 1525 | 0.070 |
Why?
| | Noise | 1 | 2009 | 68 | 0.070 |
Why?
| | Diabetic Retinopathy | 1 | 2010 | 201 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1756 | 0.070 |
Why?
| | DNA Methylation | 1 | 2012 | 640 | 0.070 |
Why?
| | Patient Satisfaction | 1 | 2012 | 690 | 0.070 |
Why?
| | DNA, Viral | 1 | 2008 | 363 | 0.060 |
Why?
| | Radiosurgery | 1 | 2010 | 389 | 0.060 |
Why?
| | Occupational Exposure | 1 | 2010 | 346 | 0.060 |
Why?
| | Child | 3 | 2023 | 22313 | 0.060 |
Why?
| | Health Services Accessibility | 2 | 2023 | 1020 | 0.060 |
Why?
| | Sexual Behavior | 1 | 2009 | 493 | 0.060 |
Why?
| | Time Factors | 1 | 2016 | 6944 | 0.060 |
Why?
| | Papillomavirus Vaccines | 1 | 2009 | 317 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2062 | 0.060 |
Why?
| | Child, Preschool | 1 | 2019 | 11462 | 0.050 |
Why?
| | Quality of Life | 2 | 2013 | 3005 | 0.050 |
Why?
| | Pennsylvania | 1 | 2024 | 134 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1251 | 0.050 |
Why?
| | Firearms | 1 | 2010 | 400 | 0.050 |
Why?
| | Gray Matter | 1 | 2024 | 86 | 0.050 |
Why?
| | Organ Size | 1 | 2024 | 477 | 0.050 |
Why?
| | Cranial Sinuses | 1 | 2022 | 15 | 0.050 |
Why?
| | Earache | 1 | 2022 | 6 | 0.050 |
Why?
| | Career Mobility | 1 | 2023 | 70 | 0.050 |
Why?
| | Skull Base | 1 | 2022 | 55 | 0.050 |
Why?
| | Neck Pain | 1 | 2022 | 27 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2022 | 240 | 0.040 |
Why?
| | Maryland | 1 | 2021 | 60 | 0.040 |
Why?
| | Inflammation | 1 | 2012 | 2891 | 0.040 |
Why?
| | Motion | 1 | 2021 | 101 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2524 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2024 | 1261 | 0.040 |
Why?
| | Telomere | 1 | 2023 | 279 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1072 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1815 | 0.040 |
Why?
| | Faculty, Medical | 1 | 2023 | 292 | 0.040 |
Why?
| | Schools | 1 | 2023 | 451 | 0.040 |
Why?
| | Acute Disease | 1 | 2022 | 1010 | 0.040 |
Why?
| | Vestibular Neuronitis | 1 | 2018 | 2 | 0.040 |
Why?
| | Movement | 1 | 2021 | 290 | 0.040 |
Why?
| | Medical History Taking | 1 | 2018 | 117 | 0.040 |
Why?
| | Syncope | 1 | 2018 | 57 | 0.040 |
Why?
| | Physical Examination | 1 | 2018 | 242 | 0.030 |
Why?
| | Neurology | 1 | 2018 | 112 | 0.030 |
Why?
| | Acoustic Impedance Tests | 1 | 2016 | 13 | 0.030 |
Why?
| | Cotinine | 1 | 2016 | 78 | 0.030 |
Why?
| | Pressure | 1 | 2016 | 228 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2791 | 0.030 |
Why?
| | Cadaver | 1 | 2016 | 301 | 0.030 |
Why?
| | Patient Safety | 1 | 2018 | 334 | 0.030 |
Why?
| | Acceleration | 1 | 2014 | 36 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1643 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1968 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1491 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 852 | 0.030 |
Why?
| | Hospitalization | 1 | 2024 | 2261 | 0.030 |
Why?
| | Salivary Glands | 1 | 2012 | 36 | 0.020 |
Why?
| | Cues | 1 | 2015 | 323 | 0.020 |
Why?
| | Surgical Instruments | 1 | 2012 | 50 | 0.020 |
Why?
| | CpG Islands | 1 | 2012 | 163 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2190 | 0.020 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2012 | 68 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1856 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2012 | 79 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2012 | 468 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 508 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 837 | 0.020 |
Why?
| | Software | 1 | 2016 | 676 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 374 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 674 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 856 | 0.020 |
Why?
| | Homosexuality | 1 | 2009 | 17 | 0.020 |
Why?
| | Heterosexuality | 1 | 2009 | 42 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1240 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2011 | 527 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1441 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2012 | 1430 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1313 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2497 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5194 | 0.010 |
Why?
| | Prognosis | 1 | 2011 | 4060 | 0.010 |
Why?
| | Animals | 1 | 2019 | 37579 | 0.010 |
Why?
|
|
Agrawal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|